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Staphylococcal  nuclease  is  a  well-characterized  extracellular  enzyme  pro- 
duced  by  Staphylococcus  aureus  (1).  The  amino  acid  sequence  and  three- 
dimensional  crystallographic  structure  of  this  protein  have  been determined 
(2,  3).  Furthermore,  a  variety of peptide fragments of this enzyme have been 
characterized  (4-6).  Previous  immunochemical  studies  of  nuclease  (Nase)  I 
have shown that antibody populations specific for individual antigenic regions 
of the molecule can be isolated by means of successive immunoabsorption to 
peptide fragments of decreasing size  (7),  and  that inactivation  of enzymatic 
activity by such antibodies provides a very sensitive means of quantitating the 
antibody-antigen interaction (8). 
In the course of immunization of inbred mice with Nase, a marked difference 
was observed in the ability of two different strains to produce antibodies under 
identical conditions of immunization. Since Nose offers certain immunochemical 
advantages  compared  to  other  native  proteins  for  which  genetic  control  of 
immune responsiveness has been described  (9-11),  a  detailed investigation of 
possible  differences  in  response  potential  was  made  using  inbred,  congenic 
resistant,  and  recombinant  lines  of mice.  This  report  presents  evidence  for 
genetic control of levels of antibody production to Nase in mice and  describes 
the  localization  of  the  gene(s)  responsible  for  this  control  within  the  major 
histocompatibility complex (11-2). 
Materials and Methods 
M/co.--Adult male mice, 8-12 wk of age, were used throughout the experiments. DBA/2 
and BALB/c mice were obtained from the Animal Production Unit, National  Institutes of 
Health, Bethesda, Md. B10.A(4R) recombinant mice were kindly provided by Dr. Jack H. 
Sfimpfling, The McLaughlin Institute,  Great  Falls, Mont. B10.A(2R)and B10.A(5R)were 
obtained from Mr. S. Poiley, Mammalian Genetics and Animal Production Section, National 
I Abbreviations used in this paper: H-2,  histocompatibility complex; Ir, immune response; 
Nase, nuclease; (Phe, G)-Pro--L,  poly  (LPhe, LGlu)-polyLPro--polyLLys; (T,  G)-Pro--L, 
poly (LTyr, LGlu)-polyxPro--polyLLys. 
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Cancer  Institute, Bethesda,  Md.  Other  mouse strains were purchased  from  the Jackson 
Laboratory,  Bar Harbor, Me. [(DBA/1 X  SJL/J)FI X  (DBA/1  X  SJL/J)F1]F~ mice were 
raised in our animal rooms from stock purchased from the Jackson Laboratory. 
Antigem.--Staphylococcal nuclease (Nase) was prepared and purified by one of us (DHS) 
as previously described (7), using facilities kindly made available by Dr. C. B. Anfinsen in 
the Laboratory  of Chemical Biology, National Institute of Arthritis,  Metabolic and Diges- 
tive Diseases, National Institutes of Health, Bethesda, Md. 
Poly (LTyr, LGlu)-polyLPro-  -polyLLys, abbreviated  (T, G)-Pro- -L, was a gift from Dr. 
Edna Mozes, Department of Chemical Immunology, The Weizmann Institute of Science, 
Rehovot, Israel. 
Immunizationa.--Mice were immunized with a single intraperitoneal  injection of 100/zg 
of Nase in 0.1  ml NaC1 emulsified with  an equal volume of complete Freund's adjuvant 
(Difco Laboratories, Detroit, Mich.), and bled from the retroorbital plexus 3 wk later. 
The F2 progeny mice immunized with Nase were injected intraperitoneaUy with 10/zg 
of (T, G)-Pro- -L in complete Freund's adjuvant 3 wk after Nase immunization. These ani- 
mais were boosted with 10/zg of soluble (T, G)-Pro- -L 3 wk later and bled 2 wk after boost- 
ing (12). 
Assays for Anti-Nase and Anti-(T, G)-Pro- -L Antibodies.--20/zl of a 5/~g/ml solution of 
Nase in 0.1% bovine serum albumin was mixed with 10 #1 of the antiserum being tested in 
the well of a siliconized microtiter plate (Cooke Engineering, Alexandria, Va.) and incubated 
for 5 rain at room temperature.  10 #1 of this mixture was then added to a cuvette containing 
1.0 ml of a 50/zg/ml solution of heat-denatured  DNA (13) in 0.025 M Tris Buffer, pH 8.8, 
containing  0.01 M Ca. The change in ODse0 was then recorded on a Gilford Model 2000 mul- 
tiple sample absorbance recorder equipped with a Beckman DU spectrophotometer. Generally 
three antiserum samples and one control sample, in which serum was replaced by saline in the 
initial incubation,  were run simultaneously. The units of enzymatic activity (one unit = 
1.00D280  U/rain) in the experimental cuvettes were then subtracted  from the units of ac- 
tivity in the control cuvettes, and the difference  was corrected according to the value obtained 
that day for a standard goat antinuclease antiserum of known activity.  Antiserum activity 
was expressed as units of Nase inactivated per milliliter of serum. 
Sera of F~ progeny mice were assayed for anti-(T, G)-Pro- -L activity by passive micro- 
hemagglutination as previously described (1). 
tt-2 Typing.--The  H-2 type of the [(DBA/1  X  SJL/J)F1  X  (DBA/1  X  SJL/J)F1]F2 
mice was determined by the hemagglutination method of Kaliss (14). Anti-//-2  a and anti- 
tt-g* alloantisera were prepared by reciprocally immunizing SJL/J and DBA/1 animals with 
2 X  l0  T  lymphoid cells (spleen, lymph nodes, and thymus) given intraperitoneally at weekly 
intervals for five injections. Animals were bled 1 wk after the last immunization. 
RESULTS 
Antibody  Response  to Nase in Inbred  Mouse  Strains.--Pooled  or individual 
sera from a variety of inbred mouse strains were assayed by the Nase enzymatic 
inactivation method. The results, shown in Table I, indicate that the inactiva- 
tion capacity of the sera from different strains could be divided into two cate- 
gories without overlap: those that inactivated more than 10 U  of Nase,  and 
those that inactivated less than 4  U  of the enzyme. From the distribution of 
responses shown,  ability to  make  anti-Nase antibody conformed to  the//-2 
type of the animals. Thus, of the strains tested, t/-2  °' a, k, a mice were all high 
responders  to  Nase,  whereas  H-2  b, q  animals were  low  antibody producers. 
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the observation that two groups of congenic resistant mouse strains C57BL/10, 
B10.A,  and  B10.D2;  and  CaH/HeJ  and  C3H.SW,  which  differ  only at  H-2 
within each group, also differed in their response potential  to Nase  (compare 
in Table I, line 3 with lines 2 and 7, and line 4 with line 9). 
tt-2 Linkage of the Immune Response Gene Controlling  Antibody Response to 
Nase in SJL/J and DBA/1  mice.--Because  the results presented  in  the pre- 
ceding section  suggested possible 1t-2 linkage of the Ir gene controlling anti- 
body responsiveness to Nase,  classical  genetic verification of this observation 
was attempted  using SJL/J,  DBA/1, (DBA/1  X  SJL/J)F1, and [(DBA/1  X 
SJL/J)F1 X  (DBA/1 X  SJL/J)F1]F2 mice. These two parental strains seemed 
TABLE I 
Anti-Staphylococcal Nndease Antibody Responses in Different Mouse Strains* 
Units of nuclease 
Mouse strain  H-2 type  (Inactivated/ml serum 4- SE) 
A/J  a  17.9  4-  1.0 
B10.A  a  11.8 4-  1.0 
C57BL/10  b  3.9  4-  0.8 
C3H.SW  b  1.4 
DBA/2  d  14.0 
BALB/c  d  15.8 
B10.D2  d  16.4 ±  1.2 
AKR/J  k  10.3 
C3H/HeJ  k  11.0 
C57.BR  k  14.5  4-  1.1 
DBA/1  q  1.3  4-  1.1 
SJL/J  s  17.9 4-  1.2 
* Four to five mice of each strain were injected intraperitoneally with 100 gg Nase in 
complete Freund's adjuvant.  Mice were bled 3 wk later and  their sera were assayed for 
anti-Nase activity by the enzymatic  inactivation method. Sera were assayed from individual 
mice in those cases where standard errors are shown. Otherwise, the assays were from serum 
pools. 
particularly  appropriate for this genetic study because  they have previously 
been  shown to  be  high  and low responders  for two non-H-2-1inked Ir genes 
(11,  12),  including  the  It-3  gene  controlling  response  to  (T,G)-Pro--L in 
SJL/J  and  DBA/I mice  (12).  For  a  multideterminant  immunogen  such  as 
Nase (7, 15), it seemed possible that responsiveness could be H-2 linked in some 
strains,  but not necessarily linked to the major histocompatibility complex in 
the  SJL/J  and  DBA/1  combinations.  SJL/J,  DBA/1,  and  the  F1  and  F2 
progeny of these two strains were immunized by the standard protocol. These 
sera were assayed for anti-Nase activity, and the animals typed for It-2. The 
same  F~  animals  were  subsequently  immunized  and  boosted with  10  /,g  of 
(T, G)-Pro- -L, bled,  and their sera were  titered for anti-(T, G)-Pro--L anti- 
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using SJL/J mice (high  responders to both inmmnogens)  to exclude possible 
antigenic  competition  between  Nase  and  (T, G)-Pro--L  (data  not  shown). 
Results  of individual  Nase  and  (T,G)-Pro--L antibody responses for 19  F2 
progeny,  as well  as their  respective H-2 types  are summarized in Table II. 
The mean Nase responses (excluding mouse 8)  of the three tt-2 classes of F2 
progeny, as well as the parental and F1 responses are graphically illustrated in 
Fig.  1.  The anti-Nase response potential of all the F2 mice tested  (with  one 
TABLE II 
It-2  Type,  Anti-Staphylococcal Nuclease, and  Anti-(T,  G)-Pro--L  Antibody  Responses in 
(DBA/1 X  SJL/Y)F2 Mice* 
Units of nuclease  Anti-(T,  G)-Pro-  -L 
Mouse  H-2 type  (Inactivated]ml  serum)  hemagglutination  titer 
l  s/s  18.2  1:16 
2  q/s  18.2  1:16 
3  s/s  16.1  1:32 
4  q/s  14.6  1:16 
5  s/s  18.4  1:64 
6  s/s  16.0  1:4 
7  s/s  18.4  NT 
8  q/q  11.1  1:8 
9  q/s  13.0  1:4 
10  q/s  10.1  1:16 
11  q/q  2.1  1:16 
12  q/s  13.0  1:32 
13  q/q  3.1  1:8 
14  s/s  19.3  1:8 
15  q/s  18.6  1:32 
16  q/s  17.7  1:8 
17  q/s  18.4  1:32 
18  q/q  3.5  1:8 
19  q/s  16.0  1:16 
* Mice were injected intraperitoneally with 100 #g Nase in complete Freund's adjuvant 
and bled 3 wk later. Their sera were assayed for anti-nuclease activity by the enzymatic inac- 
tivation method. 
BIT, not tested. 
exception) correlated well with H-2 type. The sera of all s/s and q/s animals 
inactivated more than  10 U  of Nase, whereas sera from the mice that typed 
q/q inactivated less than 4 U  of enzymatic activity. One mouse (no. 8) which 
repeatedly typed q/q was a high responder. This animal is being progeny tested 
for possible genetic recombination. The anti-(T,G)-Pro--L hemagglutination 
titers of the 19 mice are shown in the right column of Table II. Neither the H-2 
type nor the Nase response potential correlated with responsiveness to (T, G)- 
Pro- -L. This confirms the published results of Mozes et al. (12)  that the It-3 
gene controlling antibody response to (T, G)-Pro- -L is not H-2 linked. 1208  GENETIC  CONTROL  OF  IMMUNITY  TO  NUCLEASE.  I 
20 
18 















-  8 
Z 




u.T  ~  sis  q/s  q/q 
J  c~  H-2  YPE 





FIo.  1.  Anti-Nase  antibody  responses  in  SJL/J, DBA/1,  (DBA/1  X  SJL/J)F1,  and 
(DBA/1  X  SJL/J)F2  mouse strains,  4-SE. "lhe responses of the F~ progeny  are separated 
according to their H-2 type and, for comparison purposes, illustrated with the same shading 
as the corresponding parental or F1 or H-2 type. 
Intra-//-2 Localization of Ir-Nase.--In order to map the Ir gene  controlling 
responsiveness  to Nase within  the major histocompatibility  complex,  use was 
made  of  the  B10.A(2R),  B10.A(4R),  and  B10.A(5R)  recombinant  strains  in 
which  three  distinct  crossovers have  been  demonstrated  within//-2  (16,  17). 
C57BL/10,  B10.A,  and  the  three  recombinant  strains  were  immunized  with EUGENE  C.  LOZNER,  DAVID H.  SACHS,  GENE  M.  SHEARER  1209 
Nase.  Sera from the individual mice were assayed for anti-Nase activity. The 
results are shown in Fig. 2, along with the corresponding H-2 types and dia- 
grams of the crossovers of the recombinants.  B10.A(2R) mice were the highest 
responders  among  the  recombinants  tested,  whereas  the  B10.A(4R)  and 
B10.A(5R)  were low responders.  These results map the gene controlling anti- 
body response to Nase to the same region as the gene regulating responsiveness 
to mouse  IgG myeloma (17) and distinct from the region(s)  controlling  re- 
sponses to mouse IgA myeloma (17), and the A- -L series of branched chain 
synthetic polypeptides (18). 
MAJOR  HISTOCOMPATIBILITY  UNITS OFNUCLEASE 
H-2  COMPLEX  INACTIVATEO/ml 
MOUSE STRAIN  TYPE  SERUM +SE 
H-2K  Ir-I  Ir-IgG Ss-SIp H-2D 
C57BL/IO  b  I  I  I  I  I  3.9:1:0.8 
I  I  I  I  I 
BIO.A  o  ~  11.8:1:1.0 
BIO.A(2R)  h"2"  8.0 :t: 1.9 
BIO-A(4R)  h"4"  2.0-1-0.5 
BIO'A(5R)  i  ~  1.6-=-0.6 
FIo. 2. Anfi-Nase antibody responses of C57BL/10, B10.A, B10.A(2R), B10.A(4R), and 
B10.5(SR)  congenic resistant  mouse strains.  Schematic diagrams  of the  major  histocom- 
patibility complex of each strain  are illustrated  to show the relationship  of the anti-Nase 
response to the Ir-IgG subregion of H-2. 
DISCUSSION 
Genetic control  of antibody responses in mice has been demonstrated for a 
number of defined synthetic immunogens composed of mulfichain (12, 19-21) 
and linear polypeptides (22-24). For more complex immunogens, genetic regu- 
lation of responsiveness in this species has been reported for limiting immuno- 
genic doses of certain proteins (9,  10). This dose-dependent  expression of Ir 
genes  was  attributed  to  immunological  stimulation by  those  determinants 
which were both most immunopotent and under the control  of a specific If 
gene  (25). It is possible therefore,  that heredity influences responsiveness  to 
many complex immunogens,  although such control may go undetected due to 
the animal's response potential to different antigenic  moieties not being con- 
trolled by a particular Ir gene. This hypothesis has been  verified using the 
multichain  synthetic  polypeptide  poly  (LPhe,LGlu)-polyLPro- -polyLLys 
[(Phe, G)-Pro- -L] (21), and more recently with the "loop" peptide of lysozyme 1210  GENETIC  CONTROL  OF  IMMUNITY  TO  NUCLEASE.  I 
(11). Thus, although both the SJL/J and DBA/1 mouse strains responded to 
(Phe, G)-Pro- -L, the antibodies synthesized by the former strain were specific 
for Pro- -L, whereas the antibodies from the latter strain were directed mainly 
toward the (Phe, G) portion of the molecule (21). In the case of lysozyme, all 
mouse strains tested  (with one exception) responded to the intact lysozyme 
molecule.  However,  the  antibodies  produced  by  some  mouse  strains  were 
directed toward determinants other than the "loop" region of the enzyme (11). 
With regard to such possible dissection of a complex macromolecule into com- 
ponents to which responsiveness may or may not be under genetic control, it is 
important to note that the relative roles of carrier and haptenic determinants in 
the Ir-controlled response to an antigen remain unclear. It seems possible, for 
example, that a genetic defect in the ability of an animal to recognize a carrier 
determinant might  preclude  response  against  a  number  of  haptenic  deter- 
minants even though the animal was capable of responding to such haptenic 
determinants on an appropriate carrier (26-28). On the other hand, there may 
also be genetic defects in ability to recognize haptenic determinants regardless 
of carrier, and these may also be controlled by the Ir region. 
Staphylococcal nuclease may have advantages over other multideterminant 
antigens in terms of potential for answering these questions. Unlike the syn- 
thetic polypepfide antigens, nuclease is a naturally occurring protein and has 
inherent enzymatic activity, which may correlate with the invasiveness of the 
staphylococcal pathogen  (29).  During evolution, the development of the im- 
mune system must have been influenced by the need to recognize and react 
against just such naturally occurring foreign proteins.  Thus nuclease should 
serve as an accurate model for dissecting early events in the afferent phase of 
immune recognition. The fact that the humoral response to the entire immuno- 
gen is genetically controlled in mice, and that the locus of control resides in the 
H-2 complex, should make possible a variety of functional studies, such as, for 
example, specific cellular cooperation (30). 
In  addition, the extensive biochemical and immunologic characterizations 
which have been previously carried out on this molecule make possible a variety 
of correlations between the antigen's structure  and functional aspects of its 
interactions with antibodies  and  cells.  The  amino  acid sequence  and  three- 
dimensional structure are known (2, 3),  and indicate that while there is con- 
siderable ordered secondary structure in the intact molecule, all of the ordering 
forces are noncovalent since there are no disulfide bridges. It is probably for 
this reason that specific cleavage of nuclease has been found to produce peptide 
fragments capable of refolding to assume the native conformation (4-6).  The 
availability of such polypeptide fragments bearing isolated antigenic deter- 
minants of the intact protein provides a tool for examining individual portions 
of the immunogen for carrier or haptenic functions. It will be interesting to 
ascertain whether there is one determinant responsible for genetic control of 
recognition of the entire molecule (i.e.  a  carrier determinant) or whether the EUGENE  C.  LOZNER,  DAVID  H.  SACHS,  GENE  M.  SHEARER  1211 
humoral  responses  to  a variety  of  individual  antigenic  determinants  (i.e. 
haptenic  determinants)  are  under  separate  genetic  control.  Very  sensitive 
methods for assessing antibody to such haptenic determinants of nuclease are 
already available  (7)  and,  in  essence,  involve inhibition by peptides  of the 
antibody-mediated  inactivation  of  enzymatic  activity  described  above.  In 
order to examine carrier determinants we are presently developing methods of 
assessing  cell-mediated  immunity  to  nuclease  in  vitro.  Preliminary  results 
indicate that there is also genetic control of this aspect of immunity similar to 
that which we have reported here for humoral immunity.  ~ 
The Ir region has  been recently subdivided  into  two  distinct  subregions. 
One subregion contains It-1 which controls responsiveness to multichain syn- 
thetic polypeptides built on a  polyDLAla--polyLLys backbone and probably 
the gene controlling responsiveness to mouse IgA myeloma (17,  18). A second 
region distinct from Ir-1 which maps to the Ss-Slp side of Ir-1, has been iden- 
tified using B10.A recombinant mouse strains. This locus was found to control 
antibody responses to mouse IgG myeloma (17).  From the results obtained 
by  immunization  of  B10.A(2R),  B10.A(4R),  and  B10.A(5R)  recombinant 
mice (see Fig. 2), which represent three distinct crossovers within 1t-2,  the Ir 
gene(s) controlling responsiveness to nuclease also appears to be localized to 
the Ir-IgG region of Ir within the major histocompatibility complex. 
While it might be tempting to attribute some functional significance to the 
fact that genetic control of immune responsiveness to nuclease has been found 
to map within the same chromosomal segment as the control of immune re- 
sponsiveness to IgG myeloma proteins, it seems more likely to us that  this 
localization is merely coincidental. The map distance between the H-2K re- 
gion and the Ss-Slp region of the H-2 complex (Fig. 2) is large enough to in- 
clude numerous Ir genes  (31). In the  absence of known allelism between Ir 
genes, the only means of localizing such genes within this region is the use of 
mice with recombinant tl-2 types in which the recombinational event divides 
responsiveness patterns. Furthermore, only if the two parental strains leading 
to a recombinant show different responses to a given immunogen can the re- 
combinant be helpful in localizing the relevant Ir gene. If all Ir genes were dis- 
tributed randomly throughout the Ir region then the number which would be 
found to map to the left or to the right of any given crossover would depend 
only on the position of the crossover within this chromosomal segment. Thus 
the only significance we would attribute to the mapping of Ir-Nase to the same 
region as Ir-IgG is that it indicates that the crossover leading to the B 10.A(4R) 
recombinant occurred sufficiently to the left of Ss-Slp to permit more than one 
(and possibly many) Ir genes to be localized to the right of that crossover but 
within the Ir region. 
2 G. M. Shearer, C. Garbarino, E. C. Lozner, D. H. Sachs, and W. D Terry. Genetic 
control of the immune response to staphylococcal nuclease. II. H-2 limited Ir gene control 
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SUMMARY 
A number of inbred and congenic resistant strains of mice were immunized 
with  staphylococcal nuclease  (Nase).  Antibody  responses were  measured  in 
the sera of the  animals  by a  sensitive method involving inhibition of enzy- 
matic  hydrolysis  of  DNA.  High  responder  strains  included  A/J,  DBA/2, 
BALB/c, AKR/J,  C57BR,  and SJL/J.  DBA/1  and C57BL/6 mice were low 
responders. The strain distribution of anti-Nase response potential was com- 
patible with the relevant immune response gene(s) being linked to the murine 
major histocompatibility complex. Linkage of this response to H-2 was demon- 
strated by the findings that:  (a)  the congenic C3H/HeJ and  C3H.SW mice 
were respectively high and low responders; (b)  the congenic lines B10.A and 
B10.D2 were high responders, whereas the C57BL/10 strain was  a  poor re- 
sponder; and  (c)  anti-Nase response potential of F~ progeny from DBA/1  X 
SJL/J  matings  correlated with  their  H-2  type.  Three  B10.A  recombinant 
lines were used to map  this Ir gene within H-2.  B10.A(4R)  was  a  high re- 
sponder  to  Nase,  whereas  B10.A(2R)  and  B10.A(5R)  were  both  low  re- 
sponders.  We wish  to propose the name Ir-Nase  for the gene(s)  controlling 
antibody responsiveness to this immunogen.  Our data indicate that Ir-Nase 
is located within the same chromosomal segment of the H-2 complex as is Ir- 
IgG. 
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